Literature DB >> 16773436

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK.

Daniel F Hayes, Stephen Ethier, Marc E Lippman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16773436     DOI： 10.1007/s10549-006-9253-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  21 in total

1.  Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.

Authors:  Christine Schröder; Karin Milde-Langosch; Florian Gebauer; Katharina Schmid; Volkmar Mueller; Ralph M Wirtz; Catherine Meyer-Schwesinger; Hartmut Schlüter; Guido Sauter; Udo Schumacher
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-31       Impact factor: 4.553

2.  [Prognostic and predictive factors of invasive breast cancer: update 2009].

Authors:  T Decker; D Hungermann; W Böcker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

3.  Use of archived specimens in evaluation of prognostic and predictive biomarkers.

Authors:  Richard M Simon; Soonmyung Paik; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2009-10-08       Impact factor: 13.506

4.  Serum HER2/ECD value in stage I and II early breast cancer: need of a lower cut-off?

Authors:  Sasha Badzek; Vesna Lesko Kelovic; Stjepko Plestina; Ines Humar; Zoran Veir; Zeljko Mihaljevic
Journal:  Wien Klin Wochenschr       Date:  2011-11-28       Impact factor: 1.704

5.  Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.

Authors:  Dina Schütze; Karin Milde-Langosch; Isabell Witzel; Achim Rody; Thomas Karn; Marcus Schmidt; Matthias Choschzick; Fritz Jänicke; Volkmar Müller
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-29       Impact factor: 4.553

Review 6.  Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.

Authors:  Xinsen Xu; Kai Qu; Qing Pang; Zhixin Wang; Yanyan Zhou; Chang Liu
Journal:  Front Med       Date:  2016-05-16       Impact factor: 4.592

7.  Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.

Authors:  Ulrike Weissenstein; Agnes Schumann; Marcus Reif; Susanne Link; Ulrike D Toffol-Schmidt; Peter Heusser
Journal:  BMC Cancer       Date:  2012-05-30       Impact factor: 4.430

8.  Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.

Authors:  Volkmar Müller; Sabine Riethdorf; Brigitte Rack; Wolfgang Janni; Peter A Fasching; Erich Solomayer; Bahriye Aktas; Sabine Kasimir-Bauer; Klaus Pantel; Tanja Fehm
Journal:  Breast Cancer Res       Date:  2012-08-15       Impact factor: 6.466

9.  Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.

Authors:  Hyuna Sung; Sujee Jeon; Kyoung-Mu Lee; Sohee Han; Minkyo Song; Ji-Yeob Choi; Sue K Park; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Daehee Kang
Journal:  BMC Cancer       Date:  2012-05-28       Impact factor: 4.430

10.  Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.

Authors:  I Witzel; S Loibl; G von Minckwitz; H Eidtmann; T Fehm; F Khandan; S Schmatloch; M Hauschild; J Bischoff; P A Fasching; C Mau; C Schem; B Rack; I Meinhold-Heerlein; C Liedtke; T Karn; J Huober; C Zu Eulenburg; Y Issa-Nummer; M Untch; V Müller
Journal:  Br J Cancer       Date:  2012-08-14       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.